Caroline Gravel Centre for Vaccine Evaluation, Biologics and Genetic Therapies Directorate, HPFB Health canada Biography Publications Institution JoVE Articles Caroline Gravel has not added a biography. If you are Caroline Gravel and would like to personalize this page please email our Author Liaison for assistance. Publications Die Wirkung Von Interferon-α über Die Expression Des Cytochrom P450 3A4 in Menschlichen Berechnete Zellen Toxicology and Applied Pharmacology. Jun, 2011 | Pubmed ID: 21466820 Optimierung Und Qualifikation Einer Quantitativen Umkehrphasen-HPLC-Methode Zur Hämagglutinin an Grippe Vorbereitungen Und Seine Vergleichende Bewertung Mit Biochemischen Proben Vaccine. Apr, 2011 | Pubmed ID: 21397719 Qualitative Und Quantitative Analysen Der Praktisch Alle Subtypen Der Grippe A Und B Virale Neuraminidasen Unter Verwendung Der Antikörper, Die Gezielt Der Universell Konservierten Sequenzen Vaccine. Aug, 2010 | Pubmed ID: 20621113 Paracetamol Moduliert Die Transkriptionelle Reaktion Auf Rekombinanten Interferon-Beta PloS One. 2010 | Pubmed ID: 20544007 Quantitative Analysen aller Influenza Typ A Viral Hämagglutininen und Neuraminidasen mit Universal Antikörper in Einfache Slot Blot Assays Caroline Gravel*1, Changgui Li*2, Junzhi Wang2, Anwar M Hashem1,3,4, Bozena Jaentschke1, Gary Van Domselaar5, Runtao He5, Xuguang Li1,3 1Centre for Vaccine Evaluation, Biologics and Genetic Therapies Directorate, HPFB, Health canada, 2National Institute for the Control of Pharmaceutical and Biological Products, The State Food and Drug Administration, Beijing, 3Department of Biochemistry, Microbiology and Immunology, University of Ottawa, 4Microbiology Department, Faculty of Medicine, King Abdulaziz University, 5National Microbiology Laboratory, Public Health Agency of Canada JoVE 2784 Immunology and Infection
Quantitative Analysen aller Influenza Typ A Viral Hämagglutininen und Neuraminidasen mit Universal Antikörper in Einfache Slot Blot Assays Caroline Gravel*1, Changgui Li*2, Junzhi Wang2, Anwar M Hashem1,3,4, Bozena Jaentschke1, Gary Van Domselaar5, Runtao He5, Xuguang Li1,3 1Centre for Vaccine Evaluation, Biologics and Genetic Therapies Directorate, HPFB, Health canada, 2National Institute for the Control of Pharmaceutical and Biological Products, The State Food and Drug Administration, Beijing, 3Department of Biochemistry, Microbiology and Immunology, University of Ottawa, 4Microbiology Department, Faculty of Medicine, King Abdulaziz University, 5National Microbiology Laboratory, Public Health Agency of Canada JoVE 2784 Immunology and Infection